Interesting read ......

  1. 170 Posts.
    lightbulb Created with Sketch. 94
    Interesting read ... https://cardiex.com/assessing-cardiovascular-risk-in-the-face-of-covid-19/

    "The gold standard for non-invasive central blood pressure and arterial stiffness measurement is ATCOR’s SphygmoCor® XCEL. ATCOR technology equips healthcare providers with vital insights into their patients’ vascular health—including but not limited to arterial stiffness, pulse wave reflections, and central aortic blood pressure. This information will be critical as we move forward in our understanding, prevention, and treatment of individuals with COVID-19."

    IMO highlights the huge potential of CDX's product uptake when they roll out their range of new, 'telemedicine ready' cardiovascular monitoring devices, based on ATCOR's Sphygmocor technology.

    GLTA Holders
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
3.9¢
Change
-0.001(2.50%)
Mkt cap ! $17.49M
Open High Low Value Volume
3.9¢ 4.0¢ 3.8¢ $20.01K 521.6K

Buyers (Bids)

No. Vol. Price($)
2 75000 3.8¢
 

Sellers (Offers)

Price($) Vol. No.
4.2¢ 60000 1
View Market Depth
Last trade - 15.40pm 27/06/2025 (20 minute delay) ?
CDX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.